Ribonucleoprotein Biogenesis and Epigenetic Gene Regulation
核糖核蛋白生物发生和表观遗传基因调控
基本信息
- 批准号:10363745
- 负责人:
- 金额:$ 65.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAllelesAmino AcidsAnimal ModelAnimalsBindingBiochemistryBiogenesisBiological ModelsBiological ProcessCellsChromatinChromosomesDevelopmentDrosophila melanogasterEpigenetic ProcessEukaryotaFoundationsGene ExpressionGene Expression RegulationGene FamilyGenesGeneticGenomeHistonesHousekeepingHumanIndividualLaboratoriesMalignant NeoplasmsMessenger RNAMissense MutationModelingMolecularMolecular GeneticsMotor NeuronsMultigene FamilyMutationNeuromuscular DiseasesPathway interactionsPatientsPlayPost-Translational Protein ProcessingProcessRNA ProcessingResearchRibonucleoproteinsRoleSeriesSmall Nuclear RibonucleoproteinsSpinal Muscular AtrophyTechniquesTimeTissuesTranscriptWorkgenome-wideinnovationinsightinterestmutantneuromuscularsurvival motor neuron genetransmission process
项目摘要
Abstract
The research in our laboratory centers on foundational mechanisms that regulate eukaryotic gene expression.
In particular, we are interested in roles played by small nuclear ribonucleoproteins (RNPs) and histone post-
translational modifications (PTMs) in the transmission of genetic and epigenetic information required for proper
metazoan development and genome function. We have developed innovative model systems in Drosophila
melanogaster to study gene regulation and neuromuscular disease. Critically, these models allow direct
interrogation of specific residues present within conserved genes and multi-gene families. For example, we can
now study the biological function of a specific histone PTM by changing the acceptor residue to an amino acid
that cannot be appropriately modified and then replacing all wild-type copies of a given histone gene with mutant
copies. This approach is not possible in other animal models. Hence, for the first time in any multicellular
eukaryote, we can now directly determine the extent to which a given histone PTM contributes to cell fate and
organismal development. Similarly, we generated an allelic series of animals that express missense mutations
in the Survival Motor Neuron (SMN) gene that are derived from human Spinal Muscular Atrophy (SMA) patients.
This series represents the largest number of SMA-causing point mutants currently available in any model
organism. Several of these alleles serve as separation-of-function mutations that uncouple the putative
housekeeping and tissue-specific activities of SMN, enabling us to study these processes independently. We
employ genome-wide techniques together with molecular genetics and biochemistry to identify cellular pathways
and binding partners that are dysregulated in human cancer and neuromuscular disease. Using these two
powerful genetic platforms, we expect to identify factors and mechanisms that enable a specific chromatin mark
to modulate the expression of an individual transcript or an entire chromosome, as well as those that carry out
the assembly and maturation of spliceosomal and messenger RNPs.
抽象的
我们实验室的研究重点是调节真核基因表达的基本机制。
我们特别对小核核糖核蛋白(RNP)和组蛋白后发挥的作用感兴趣。
正确传递所需的遗传和表观遗传信息的翻译修饰(PTM)
后生动物发育和基因组功能。我们开发了果蝇创新模型系统
黑腹果蝇研究基因调控和神经肌肉疾病。至关重要的是,这些模型允许直接
询问保守基因和多基因家族中存在的特定残基。例如,我们可以
现在通过将受体残基更改为氨基酸来研究特定组蛋白 PTM 的生物学功能
无法进行适当修改,然后用突变体替换给定组蛋白基因的所有野生型副本
副本。这种方法在其他动物模型中是不可能的。因此,在任何多细胞生物中,这是第一次
对于真核生物,我们现在可以直接确定给定组蛋白 PTM 对细胞命运的贡献程度,
有机体的发育。同样,我们生成了一系列表达错义突变的等位基因动物
存在于源自人类脊髓性肌萎缩症 (SMA) 患者的运动神经元生存 (SMN) 基因中。
该系列代表了目前所有模型中数量最多的 SMA 致病点突变体
生物。其中一些等位基因充当功能分离突变,将假定的
SMN 的内务管理和组织特异性活动,使我们能够独立研究这些过程。我们
采用全基因组技术以及分子遗传学和生物化学来识别细胞途径
以及在人类癌症和神经肌肉疾病中失调的结合伙伴。使用这两个
强大的遗传平台,我们期望识别出实现特定染色质标记的因素和机制
调节单个转录本或整个染色体的表达,以及那些执行
剪接体和信使 RNP 的组装和成熟。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
A. Gregory Matera其他文献
A. Gregory Matera的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('A. Gregory Matera', 18)}}的其他基金
Ribonucleoprotein Biogenesis and Epigenetic Gene Regulation
核糖核蛋白生物发生和表观遗传基因调控
- 批准号:
10588149 - 财政年份:2020
- 资助金额:
$ 65.23万 - 项目类别:
Epigenetic control of metazoan transcription and pre-mRNA processing by histone PTMs
组蛋白 PTM 对后生动物转录和前 mRNA 加工的表观遗传控制
- 批准号:
9891676 - 财政年份:2018
- 资助金额:
$ 65.23万 - 项目类别:
In vivo models of small RNP biogenesis and Spinal Muscular Atrophy
小 RNP 生物发生和脊髓性肌萎缩症的体内模型
- 批准号:
9251862 - 财政年份:2016
- 资助金额:
$ 65.23万 - 项目类别:
Coilin, Cajal Bodies and Spinal Muscular Atrophy
线圈、卡哈尔体和脊髓性肌萎缩症
- 批准号:
6540448 - 财政年份:2001
- 资助金额:
$ 65.23万 - 项目类别:
Coilin, Cajal Bodies and Spinal Muscular Atrophy
线圈、卡哈尔体和脊髓性肌萎缩症
- 批准号:
7017076 - 财政年份:2001
- 资助金额:
$ 65.23万 - 项目类别:
Coilin, Cajal Bodies and Spinal Muscular Atrophy
线圈、卡哈尔体和脊髓性肌萎缩症
- 批准号:
6335781 - 财政年份:2001
- 资助金额:
$ 65.23万 - 项目类别:
Coilin, Cajal Bodies and Spinal Muscular Atrophy
线圈、卡哈尔体和脊髓性肌萎缩症
- 批准号:
7600366 - 财政年份:2001
- 资助金额:
$ 65.23万 - 项目类别:
Coilin, Cajal Bodies and Spinal Muscular Atrophy
线圈、卡哈尔体和脊髓性肌萎缩症
- 批准号:
6639770 - 财政年份:2001
- 资助金额:
$ 65.23万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 65.23万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 65.23万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 65.23万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 65.23万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 65.23万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 65.23万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 65.23万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 65.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 65.23万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 65.23万 - 项目类别:














{{item.name}}会员




